Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.89 - $2.36 $5,172 - $13,716
-5,812 Reduced 16.14%
30,200 $26,000
Q1 2024

May 14, 2024

BUY
$0.73 - $2.73 $8,906 - $33,306
12,200 Added 51.23%
36,012 $84,000
Q3 2023

Nov 13, 2023

BUY
$0.79 - $2.83 $18,811 - $67,387
23,812 New
23,812 $20,000
Q1 2023

May 12, 2023

BUY
$15.95 - $25.18 $3.71 Million - $5.85 Million
232,435 New
232,435 $4.34 Million
Q4 2021

Feb 14, 2022

SELL
$9.93 - $15.39 $303,013 - $469,625
-30,515 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$10.18 - $26.64 $104,039 - $272,260
-10,220 Reduced 25.09%
30,515 $312,000
Q2 2021

Aug 16, 2021

SELL
$18.57 - $35.68 $37,882 - $72,787
-2,040 Reduced 4.77%
40,735 $1.09 Million
Q1 2021

May 12, 2021

SELL
$31.0 - $55.72 $5.54 Million - $9.95 Million
-178,560 Reduced 80.67%
42,775 $1.49 Million
Q4 2020

Feb 16, 2021

SELL
$37.09 - $48.97 $1.33 Million - $1.75 Million
-35,770 Reduced 13.91%
221,335 $8.21 Million
Q3 2020

Nov 16, 2020

SELL
$40.47 - $45.5 $132,417 - $148,876
-3,272 Reduced 1.26%
257,105 $10.6 Million
Q2 2020

Aug 12, 2020

SELL
$32.57 - $42.83 $2.6 Million - $3.42 Million
-79,873 Reduced 23.47%
260,377 $10.6 Million
Q1 2020

May 12, 2020

SELL
$23.3 - $45.96 $1.85 Million - $3.65 Million
-79,417 Reduced 18.92%
340,250 $11.8 Million
Q4 2019

Feb 11, 2020

SELL
$34.58 - $48.06 $1.29 Million - $1.79 Million
-37,206 Reduced 8.14%
419,667 $18 Million
Q3 2019

Nov 13, 2019

BUY
$36.98 - $48.45 $11.7 Million - $15.4 Million
317,090 Added 226.84%
456,873 $16.9 Million
Q2 2019

Aug 08, 2019

BUY
$35.13 - $55.53 $4.91 Million - $7.76 Million
139,772 Added 1270654.5%
139,783 $0
Q1 2019

Aug 05, 2021

SELL
$42.83 - $59.91 $2.85 Million - $3.99 Million
-66,549 Reduced 99.98%
11 $1,000
Q1 2019

May 15, 2019

BUY
$42.83 - $59.91 $2.85 Million - $3.99 Million
66,526 Added 195664.7%
66,560 $0
Q4 2018

Aug 05, 2021

SELL
$37.97 - $60.16 $3.65 Million - $5.79 Million
-96,258 Reduced 99.96%
34 $2,000
Q4 2018

Feb 07, 2019

SELL
$37.97 - $60.16 $1.49 Million - $2.36 Million
-39,298 Reduced 28.98%
96,292 $4.46 Million
Q3 2018

Nov 07, 2018

SELL
$56.3 - $67.25 $11.6 Million - $13.8 Million
-205,749 Reduced 60.28%
135,590 $0
Q2 2018

Aug 13, 2018

SELL
$44.9 - $64.95 $1.47 Million - $2.13 Million
-32,820 Reduced 8.77%
341,339 $0
Q1 2018

May 04, 2018

BUY
$45.35 - $61.65 $3.73 Million - $5.08 Million
82,340 Added 28.22%
374,159 $0
Q4 2017

Feb 13, 2018

SELL
$41.95 - $60.1 $607,477 - $870,308
-14,481 Reduced 4.73%
291,819 $13.8 Million
Q3 2017

Nov 02, 2017

BUY
$33.4 - $53.9 $10.2 Million - $16.5 Million
306,300
306,300 $16.5 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.